{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:27:52Z","timestamp":1792679272902,"version":"4.5.0"},"reference-count":169,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Oncode Institute","award":["-"],"award-info":[{"award-number":["-"]}]},{"name":"ADPS Longevity Research Award","award":["-"],"award-info":[{"award-number":["-"]}]},{"name":"Regiodeal Foodvalley","award":["162135"],"award-info":[{"award-number":["162135"]}]},{"name":"BBoL (NWO-ENW)","award":["737.016.015"],"award-info":[{"award-number":["737.016.015"]}]},{"name":"ZonMW Memorabel","award":["733050810"],"award-info":[{"award-number":["733050810"]}]},{"name":"EJP-RD","award":["RD20-113"],"award-info":[{"award-number":["RD20-113"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Recent advances have increased survival rates of children and adults suffering from cancer thanks to effective anti-cancer therapy, such as chemotherapy. However, during treatment and later in life they are frequently confronted with the severe negative side-effects of their life-saving treatment. The occurrence of numerous features of accelerated aging, seriously affecting quality of life, has now become one of the most pressing problems associated with (pediatric) cancer treatment. Chemotherapies frequently target and damage the DNA, causing mutations or genome instability, a major hallmark of both cancer and aging. However, there are numerous types of chemotherapeutic drugs that are genotoxic and interfere with DNA metabolism in different ways, each with their own biodistribution, kinetics, and biological fate. Depending on the type of DNA lesion produced (e.g., interference with DNA replication or RNA transcription), the organ or cell type inflicted (e.g., cell cycle or differentiation status, metabolic state, activity of clearance and detoxification mechanisms, the cellular condition or micro-environment), and the degree of exposure, outcomes of cancer treatment can largely differ. These considerations provide a conceptual framework in which different classes of chemotherapeutics contribute to the development of toxicities and accelerated aging of different organ systems. Here, we summarize frequently observed side-effects in (pediatric) ex-cancer patients and discuss which types of DNA damage might be responsible.<\/jats:p>","DOI":"10.3390\/cancers14030627","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T04:49:51Z","timestamp":1643258991000},"page":"627","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":442,"title":["Chemotherapy Side-Effects: Not All DNA Damage Is Equal"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5712-3990","authenticated-orcid":false,"given":"Winnie M. C.","family":"van den Boogaard","sequence":"first","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"},{"name":"Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3893-3389","authenticated-orcid":false,"given":"Daphne S. J.","family":"Komninos","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"},{"name":"Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9690-1385","authenticated-orcid":false,"given":"Wilbert P.","family":"Vermeij","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands"},{"name":"Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ctrv.2010.02.003","article-title":"Epidemiology of childhood cancer","volume":"36","author":"Kaatsch","year":"2010","journal-title":"Cancer Treat. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejca.2021.08.001","article-title":"Significant improvement in survival of advanced stage childhood and young adolescent cancer in the Netherlands since the 1990s","volume":"157","author":"Schulpen","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3322\/caac.21219","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.1946.02870380008004","article-title":"Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin\u2019s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders","volume":"132","author":"Goodman","year":"1946","journal-title":"J. Am. Med. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid","volume":"238","author":"Farber","year":"1948","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1182\/blood.V13.12.1126.1126","article-title":"A comparative study of two regimens of combination chemotherapy in acute leukemia","volume":"13","author":"Frei","year":"1958","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/djy229","article-title":"Premature Aging in Young Cancer Survivors","volume":"111","author":"Armenian","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e000250","DOI":"10.1136\/esmoopen-2017-000250","article-title":"Biology of premature ageing in survivors of cancer","volume":"2","author":"Kirkland","year":"2017","journal-title":"ESMO Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/jnci\/djz136","article-title":"Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors","volume":"111","author":"Guida","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mehy.2006.01.045","article-title":"Possible acceleration of aging by adjuvant chemotherapy: A cause of early onset frailty?","volume":"67","author":"Maccormick","year":"2006","journal-title":"Med. Hypotheses"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijo.2018.4661","article-title":"From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)","volume":"54","author":"Schirrmacher","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wang, S., Prizment, A., Thyagarajan, B., and Blaes, A. (2021). Cancer Treatment-Induced Accelerated Aging in Cancer Survivors: Biology and Assessment. Cancers, 13.","DOI":"10.3390\/cancers13030427"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.15252\/emmm.201607062","article-title":"After surviving cancer, what about late life effects of the cure?","volume":"9","author":"Nonnekens","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1289\/ehp.94102s11111","article-title":"Pharmacokinetics in the child","volume":"102","author":"Crom","year":"1994","journal-title":"Environ. Health Perspect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.21273","article-title":"Improving the outcome for children with cancer: Development of targeted new agents","volume":"65","author":"Adamson","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/35077232","article-title":"Genome maintenance mechanisms for preventing cancer","volume":"411","author":"Hoeijmakers","year":"2001","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/cas.13455","article-title":"DNA replication stress and cancer chemotherapy","volume":"109","author":"Kitao","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/ndt\/17.11.1931","article-title":"Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation","volume":"17","author":"Caglar","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1871520614666140127105809","article-title":"Anti-cancer agent-induced nephrotoxicity","volume":"14","author":"Fukasawa","year":"2014","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.297.24.2705","article-title":"Medical assessment of adverse health outcomes in long-term survivors of childhood cancer","volume":"297","author":"Geenen","year":"2007","journal-title":"Jama"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kidera, Y., Kawakami, H., Sakiyama, T., Okamoto, K., Tanaka, K., Takeda, M., Kaneda, H., Nishina, S.-I., Tsurutani, J., and Fujiwara, K. (2014). Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101902"},{"key":"ref_24","first-page":"924","article-title":"Nephrotoxicity of anticancer treatment","volume":"32","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: A review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of Cisplatin Nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.ackd.2019.08.005","article-title":"Nephrotoxic Chemotherapy Agents: Old and New","volume":"27","author":"Nicolaysen","year":"2020","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: A review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.semnephrol.2010.09.005","article-title":"Nephrotoxicity from chemotherapeutic agents: Clinical manifestations, pathobiology, and prevention\/therapy","volume":"30","author":"Perazella","year":"2010","journal-title":"Semin. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/ijpvm.IJPVM_40_17","article-title":"Prevention of chemotherapy-induced nephrotoxicity in children with cancer","volume":"8","author":"Sharbaf","year":"2017","journal-title":"Int. J. Prev. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00003495-199957020-00002","article-title":"Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer","volume":"57","author":"Hoekman","year":"1999","journal-title":"Drugs"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/tx900242k","article-title":"An overview of chemical processes that damage cellular DNA: Spontaneous hydrolysis, alkylation, and reactions with radicals","volume":"22","author":"Gates","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5306\/wjco.v11.i4.190","article-title":"Nephrotoxicity in cancer treatment: An overview","volume":"11","author":"Santos","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: Golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ckj\/sft135","article-title":"Nephrotoxicity of recent anti-cancer agents","volume":"7","author":"Lameire","year":"2013","journal-title":"Clin. Kidney J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/mi.7.3.6","article-title":"Collateral damage in cancer chemotherapy: Oxidative stress in nontargeted tissues","volume":"7","author":"Chen","year":"2007","journal-title":"Mol. Interv."},{"key":"ref_37","first-page":"15","article-title":"Chemotherapy-associated hepatotoxicity in colorectal cancer","volume":"14","author":"Cai","year":"2014","journal-title":"Vascular"},{"key":"ref_38","first-page":"95","article-title":"Hepatotoxicity secondary to chemotherapy","volume":"2","author":"Grigorian","year":"2014","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cld.2013.07.010","article-title":"Chemotherapy-Induced Hepatotoxicity","volume":"17","author":"Thatishetty","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1148\/radiol.10092129","article-title":"CT findings of chemotherapy-induced toxicity: What radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity","volume":"258","author":"Torrisi","year":"2011","journal-title":"Radiology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.5719","article-title":"Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases","volume":"94","author":"Zorzi","year":"2007","journal-title":"J. Br. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.seminoncol.2005.11.002","article-title":"Hepatotoxicity of Chemotherapy","volume":"33","author":"Floyd","year":"2006","journal-title":"Semin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1634\/theoncologist.6-2-162","article-title":"Hepatotoxicity of chemotherapy","volume":"6","author":"King","year":"2001","journal-title":"Oncologist"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Guha, C., and Kavanagh, B.D. (2011). Hepatic radiation toxicity: Avoidance and amelioration. Seminars in Radiation Oncology, WB Saunders.","DOI":"10.1016\/j.semradonc.2011.05.003"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/WCO.0000000000000234","article-title":"Chemotherapy-induced peripheral neurotoxicity","volume":"28","author":"Cavaletti","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): An update","volume":"82","author":"Argyriou","year":"2012","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.blre.2014.09.012","article-title":"The double-edged sword: Neurotoxicity of chemotherapy","volume":"29","author":"Magge","year":"2015","journal-title":"Blood Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-016-0686-x","article-title":"Chemotherapy-related neurotoxicity","volume":"16","author":"Taillibert","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3322\/caac.21204","article-title":"Chemotherapy-induced peripheral neurotoxicity: A critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","article-title":"Cardiotoxicity of Chemotherapeutic Agents","volume":"22","author":"Pai","year":"2000","journal-title":"Drug Saf."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.med.57.121304.131240","article-title":"Cardiotoxicity induced by chemotherapy and antibody therapy","volume":"57","author":"Yeh","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00148581-200507030-00005","article-title":"Cardiotoxicity of Cancer Chemotherapy","volume":"7","author":"Simbre","year":"2005","journal-title":"Pediatr. Drugs"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2459\/JCM.0000000000000376","article-title":"Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy","volume":"17","author":"Madeddu","year":"2016","journal-title":"J. Cardiovasc. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: Incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: The need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_57","first-page":"59","article-title":"Chemotherapy-induced Cardiotoxicity","volume":"8","author":"Florescu","year":"2013","journal-title":"Maedica"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.seminoncol.2006.04.020","article-title":"Pathogenesis of cardiotoxicity induced by anthracyclines","volume":"33","author":"Elliott","year":"2006","journal-title":"Semin. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.critrevonc.2016.01.005","article-title":"Chemotherapy induced thrombocytopenia in pediatric oncology","volume":"99","author":"Tamamyan","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2165\/11594310-000000000-00000","article-title":"Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: Results from a retrospective hospital-based cohort study","volume":"34","author":"Shantakumar","year":"2011","journal-title":"Drug Saf."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/21548331.1976.11706980","article-title":"Managing chemotherapy-induced bone marrow suppression in cancer","volume":"11","author":"Lokich","year":"1976","journal-title":"Hosp. Pract."},{"key":"ref_62","first-page":"95","article-title":"Hematologic complications of cancer chemotherapy","volume":"91","author":"Hoagland","year":"1982","journal-title":"Semin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1529-8019.2002.01540.x","article-title":"Alkylating agents","volume":"15","author":"Germanas","year":"2002","journal-title":"Dermatol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-016-4028-0","article-title":"Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel\u2013cyclophosphamide chemotherapy for breast cancer: A systematic review","volume":"161","author":"Fernandes","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_65","first-page":"8","article-title":"Chemotherapy induced myelosuppression","volume":"84","author":"Waweru","year":"2007","journal-title":"East Afr. Med. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/107327480301000507","article-title":"Factors associated with early termination of CHOP therapy and the impact on survival among patients with chemosensitive intermediate-grade non-Hodgkin\u2019s lymphoma","volume":"10","author":"Chrischilles","year":"2003","journal-title":"Cancer Control"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.2000.18.7.1412","article-title":"Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII","volume":"18","author":"Crivellari","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_68","first-page":"491","article-title":"Cerebellar toxicity due to cytarabine: A series of 4 cases","volume":"7","author":"Corral","year":"2016","journal-title":"Neurol. A"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","article-title":"Cisplatin-induced nephrotoxicity and targets of nephroprotection: An update","volume":"86","author":"Martins","year":"2012","journal-title":"Arch. Toxicol."},{"key":"ref_70","first-page":"547","article-title":"Membrane transporters as mediators of cisplatin side-effects","volume":"34","author":"Ciarimboli","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","article-title":"Molecular mechanisms of resistance and toxicity associated with platinating agents","volume":"33","author":"Rabik","year":"2007","journal-title":"Cancer Treat. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"473829","DOI":"10.6064\/2012\/473829","article-title":"Membrane transporters as mediators of Cisplatin effects and side effects","volume":"2012","author":"Ciarimboli","year":"2012","journal-title":"Scientifica"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fphar.2015.00085","article-title":"Role of transporters in the distribution of platinum-based drugs","volume":"6","author":"Harrach","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1021\/cr040478b","article-title":"Formation and repair of interstrand cross-links in DNA","volume":"106","author":"Noll","year":"2006","journal-title":"Chem. Rev."},{"key":"ref_76","first-page":"57","article-title":"Prevention of cisplatin nephrotoxicity","volume":"5","author":"Hayati","year":"2016","journal-title":"J. Nephropharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/onc.2010.500","article-title":"Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress","volume":"30","author":"Martins","year":"2011","journal-title":"Oncogene"},{"key":"ref_78","first-page":"Cd008944","article-title":"Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer","volume":"3","author":"Kooijmans","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2005.01.008","article-title":"Causes of reversible nephrogenic diabetes insipidus: A systematic review","volume":"45","author":"Garofeanu","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1517\/14740338.7.2.147","article-title":"Drug-induced crystal nephropathy: An update","volume":"7","author":"Yarlagadda","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol."},{"key":"ref_82","unstructured":"Johnson-Arbor, K., and Dubey, R. (2021). Doxorubicin. StatPearls, StatPearls Publishing LLC."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3727\/095535491820873308","article-title":"DNA damage and cytotoxicity induced by metabolites of anthracycline antibiotics, doxorubicin and idarubicin","volume":"3","author":"Ferrazzi","year":"1991","journal-title":"Cancer Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"H1273","DOI":"10.1152\/ajpheart.00738.2005","article-title":"DNA damage is an early event in doxorubicin-induced cardiac myocyte death","volume":"291","author":"Sanjeev","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2013.6296","article-title":"Clinical ascertainment of health outcomes among adults treated for childhood cancer","volume":"309","author":"Hudson","year":"2013","journal-title":"Jama"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: Mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1016\/S0021-9258(18)47554-0","article-title":"Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death","volume":"262","author":"Yoshioka","year":"1987","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrc2607","article-title":"Targeting DNA topoisomerase II in cancer chemotherapy","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc1977","article-title":"Topoisomerase I inhibitors: Camptothecins and beyond","volume":"6","author":"Pommier","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/biom5031652","article-title":"Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy","volume":"5","author":"Xu","year":"2015","journal-title":"Biomolecules"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.4.6.889","article-title":"Toxicity of platinum compounds","volume":"4","author":"Hartmann","year":"2003","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_92","first-page":"1231","article-title":"Vinca alkaloids","volume":"4","author":"Moudi","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/gut.2004.062596","article-title":"Gastrointestinal complications of pelvic radiotherapy: Are they of any importance?","volume":"54","author":"Andreyev","year":"2005","journal-title":"Gut"},{"key":"ref_94","first-page":"357","article-title":"Bowel injury: Current and evolving management strategies","volume":"13","author":"Wang","year":"2003","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"15691","DOI":"10.1038\/ncomms15691","article-title":"Cellular senescence drives age-dependent hepatic steatosis","volume":"8","author":"Ogrodnik","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/1097-0142(19880601)61:11<2192::AID-CNCR2820611110>3.0.CO;2-A","article-title":"Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721","volume":"61","author":"Mollman","year":"1988","journal-title":"Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pharmtox-010919-023603","article-title":"Proteasome Inhibitor Drugs","volume":"60","author":"Fricker","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Brana, I., Zamora, E., Oristrell, G., and Tabernero, J. (2018). Cardiotoxicity. Side Effects of Medical Cancer Therapy, Springer.","DOI":"10.1007\/978-3-319-70253-7_14"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/postgradmedj-2016-134417","article-title":"Cardiovascular disease in cancer survivors","volume":"93","author":"Okwuosa","year":"2017","journal-title":"Postgrad. Med. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"15182","DOI":"10.1073\/pnas.1922072117","article-title":"Uncoupling DNA damage from chromatin damage to detoxify doxorubicin","volume":"117","author":"Qiao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJMcibr1214975","article-title":"Anthracyclines and Heart Failure","volume":"368","author":"Sawyer","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_103","first-page":"460","article-title":"Effect of anthracycline antibiotics on oxygen radical formation in rat heart","volume":"43","author":"Doroshow","year":"1983","journal-title":"Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0014-5793(84)81130-8","article-title":"Hydroxyl radical production and DNA damage induced by anthracycline-iron complex","volume":"172","author":"Muindi","year":"1984","journal-title":"FEBS Lett."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1021\/bi00537a001","article-title":"Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex","volume":"21","author":"Myers","year":"1982","journal-title":"Biochemistry"},{"key":"ref_106","first-page":"1078","article-title":"Nuclear catalyzed antibiotic free radical formation","volume":"42","author":"Bachur","year":"1982","journal-title":"Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Zhi, L., Yuzhang, Z., Tianliang, H., Hisatome, I., Yamamoto, T., and Jidong, C. (2016). High uric acid induces insulin resistance in cardiomyocytes in vitro and in vivo. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147737"},{"key":"ref_108","first-page":"1","article-title":"Molecular basis of anthracycline-induced cardiotoxicity","volume":"35","year":"2007","journal-title":"Heart Metab."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.6093249","article-title":"Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II","volume":"226","author":"Tewey","year":"1984","journal-title":"Science"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0167-4781(92)90050-A","article-title":"Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development","volume":"1132","author":"Capranico","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00578564","article-title":"Adriamycin and daunomycin dose-dependent effects upon contractions of isolated rat myocytes","volume":"5","author":"Lowe","year":"1980","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ncomms2921","article-title":"Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin","volume":"4","author":"Pang","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1111\/febs.15583","article-title":"New insights into the activities and toxicities of the old anticancer drug doxorubicin","volume":"288","author":"Qiao","year":"2021","journal-title":"FEBS J."},{"key":"ref_115","first-page":"206","article-title":"Mitomycin C-enhanced superoxide and hydrogen peroxide formation in rat heart","volume":"218","author":"Doroshow","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.nano.2015.07.012","article-title":"Induction of oxidative stress by Taxol\u00ae vehicle Cremophor-EL triggers production of interleukin-8 by peripheral blood mononuclear cells through the mechanism not requiring de novo synthesis of mRNA","volume":"11","author":"Ilinskaya","year":"2015","journal-title":"Nanomedicine"},{"key":"ref_117","first-page":"2112","article-title":"Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL","volume":"56","author":"Sparreboom","year":"1996","journal-title":"Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jnci\/90.4.300","article-title":"Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: An in vitro study","volume":"90","author":"Szebeni","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/41.suppl_4.1","article-title":"Infection risk and cancer chemotherapy: The impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies","volume":"41","author":"Bow","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1001\/archinte.1988.00380120031007","article-title":"The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation","volume":"148","author":"Talcott","year":"1988","journal-title":"Arch. Intern. Med."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Okunaka, M., Kano, D., Matsui, R., Kawasaki, T., and Uesawa, Y. (2021). Comprehensive Analysis of Chemotherapeutic Agents That Induce Infectious Neutropenia. Pharmaceuticals, 14.","DOI":"10.3390\/ph14070681"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/cncr.22939","article-title":"Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy","volume":"110","author":"Shayne","year":"2007","journal-title":"Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline","volume":"24","author":"Smith","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2013.12.006","article-title":"Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review","volume":"90","author":"Lyman","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/tropej\/fmi010","article-title":"Pancytopenia in children: Etiological profile","volume":"51","author":"Bhatnagar","year":"2005","journal-title":"J. Trop. Pediatr."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/cncr.29779","article-title":"Ototoxicity and cancer therapy","volume":"122","author":"Landier","year":"2016","journal-title":"Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer","volume":"77","author":"Bokemeyer","year":"1998","journal-title":"Br. J. Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPH.0b013e318059c220","article-title":"Ototoxicity from cisplatin therapy in childhood cancer","volume":"29","author":"Coradini","year":"2007","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41698-021-00178-z","article-title":"TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study","volume":"5","author":"Meijer","year":"2021","journal-title":"NPJ Precis. Oncol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/taap.2001.9171","article-title":"Cisplatin ototoxicity: Involvement of iron and enhanced formation of superoxide anion radicals","volume":"174","author":"Dehne","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.heares.2004.10.012","article-title":"Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid","volume":"203","author":"Cappaert","year":"2005","journal-title":"Hear. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2016.09.023","article-title":"Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study","volume":"69","author":"Clemens","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijporl.2016.09.001","article-title":"Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients","volume":"90","author":"Olgun","year":"2016","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/ijc.31836","article-title":"The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicity","volume":"144","author":"Secombe","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.3748\/wjg.v20.i14.3751","article-title":"Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation","volume":"20","author":"Lee","year":"2014","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1053\/j.seminoncol.2005.12.001","article-title":"Gastrointestinal toxicity of chemotherapeutic agents","volume":"33","author":"Mitchell","year":"2006","journal-title":"Semin. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2018.03.009","article-title":"Cisplatin-induced gastrointestinal toxicity: An update on possible mechanisms and on available gastroprotective strategies","volume":"827","author":"Shahid","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Oosterom, N., Griffioen, P.H., den Hoed, M.A.H., Pieters, R., de Jonge, R., Tissing, W.J.E., van den Heuvel-Eibrink, M.M., and Heil, S.G. (2018). Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0199574"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1809332","article-title":"Pre-therapy fasting slows epithelial turnover and modulates the microbiota but fails to mitigate methotrexate-induced gastrointestinal mucositis","volume":"12","author":"Wardill","year":"2020","journal-title":"Gut Microbes"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-019-0064-5","article-title":"Radiotherapy toxicity","volume":"5","author":"Niedermann","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/028418699431564","article-title":"Aspects on reducing gastrointestinal adverse effects associated with radiotherapy","volume":"38","author":"Henriksson","year":"1999","journal-title":"Acta Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jncimonographs\/lgi006","article-title":"Mechanisms of Toxic Damage to Spermatogenesis","volume":"2005","author":"Boekelheide","year":"2005","journal-title":"JNCI Monogr."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1210\/en.2015-1310","article-title":"Anti-M\u00fcllerian Hormone Is a Marker for Chemotherapy-Induced Testicular Toxicity","volume":"156","author":"Levi","year":"2015","journal-title":"Endocrinology"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/REP-12-0121","article-title":"What lies behind chemotherapy-induced ovarian toxicity?","volume":"144","author":"Shalgi","year":"2012","journal-title":"Reproduction"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fertnstert.2015.11.043","article-title":"Prevention of chemotherapy-induced ovarian damage","volume":"105","author":"Roness","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1038\/ncomms4492","article-title":"Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome","volume":"5","author":"Takemura","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_148","first-page":"614","article-title":"The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice","volume":"54","author":"Merritt","year":"1994","journal-title":"Cancer Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood-2005-04-1418","article-title":"Total body irradiation selectively induces murine hematopoietic stem cell senescence","volume":"107","author":"Wang","year":"2006","journal-title":"Blood"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.gde.2014.06.006","article-title":"Aging: Not all DNA damage is equal","volume":"26","author":"Vermeij","year":"2014","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/362709a0","article-title":"Instability and decay of the primary structure of DNA","volume":"362","author":"Lindahl","year":"1993","journal-title":"Nature"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1101\/sqb.2000.65.127","article-title":"Repair of endogenous DNA damage","volume":"65","author":"Lindahl","year":"2000","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1093\/toxsci\/kfq371","article-title":"Endogenous versus exogenous DNA adducts: Their role in carcinogenesis, epidemiology, and risk assessment","volume":"120","author":"Swenberg","year":"2011","journal-title":"Toxicol Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"101316","DOI":"10.1016\/j.arr.2021.101316","article-title":"From DNA damage to mutations: All roads lead to aging","volume":"68","author":"Vijg","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41586-021-03307-7","article-title":"The central role of DNA damage in the ageing process","volume":"592","author":"Schumacher","year":"2021","journal-title":"Nature"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-cancerbio-060820-090737","article-title":"Nutritional Preconditioning in Cancer Treatment in Relation to DNA Damage and Aging","volume":"5","author":"Hoeijmakers","year":"2021","journal-title":"Annu. Rev. Cancer Biol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tcb.2019.12.001","article-title":"Protecting the Aging Genome","volume":"30","author":"Petr","year":"2020","journal-title":"Trends Cell Biol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"738230","DOI":"10.3389\/fgene.2021.738230","article-title":"DNA Double Strand Break Repair Pathways in Response to Different Types of Ionizing Radiation","volume":"12","author":"Heemskerk","year":"2021","journal-title":"Front. Genet."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"102921","DOI":"10.1016\/j.dnarep.2020.102921","article-title":"Mammalian DNA base excision repair: Dancing in the moonlight","volume":"93","author":"Caldecott","year":"2020","journal-title":"DNA Repair"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrm3822","article-title":"Understanding nucleotide excision repair and its roles in cancer and ageing","volume":"15","author":"Marteijn","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrc3088","article-title":"DNA interstrand crosslink repair and cancer","volume":"11","author":"Deans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/MMBR.00034-08","article-title":"Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance","volume":"73","author":"Waters","year":"2009","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2005.01.027","article-title":"Understanding the odd science of aging","volume":"120","author":"Kirkwood","year":"2005","journal-title":"Cell"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMra0804615","article-title":"DNA damage, aging, and cancer","volume":"361","author":"Hoeijmakers","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/35041705","article-title":"Lessons from human progeroid syndromes","volume":"408","author":"Martin","year":"2000","journal-title":"Nature"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-pharmtox-010814-124316","article-title":"Genome Integrity in Aging: Human Syndromes, Mouse Models, and Therapeutic Options","volume":"56","author":"Vermeij","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of Intermittent Fasting on Health, Aging, and Disease","volume":"381","author":"Mattson","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1200\/EDBK_156160","article-title":"Cancer Treatment as an Accelerated Aging Process: Assessment, Biomarkers, and Interventions","volume":"35","author":"Hurria","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jamaoncol.2021.2697","article-title":"Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report","volume":"7","author":"Meijer","year":"2021","journal-title":"JAMA Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/3\/627\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:08:31Z","timestamp":1760134111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/3\/627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":169,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cancers14030627"],"URL":"https:\/\/doi.org\/10.3390\/cancers14030627","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]}}}